These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 38592819)
1. A convenient protonated strategy for constructing nanodrugs from hydrophobic drug-inhibitor conjugates to reverse tumor multidrug resistance. Wang P; Wang Y; Xia X; Wu J; Lin J; Huang W; Yan D Nanoscale; 2024 May; 16(17):8434-8446. PubMed ID: 38592819 [TBL] [Abstract][Full Text] [Related]
2. Redox-responsive drug-inhibitor conjugate encapsulated in DSPE-PEG Wang P; Wang Y; Xia X; Huang W; Yan D Biomater Sci; 2023 Jun; 11(12):4335-4345. PubMed ID: 37133364 [TBL] [Abstract][Full Text] [Related]
3. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance. Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509 [TBL] [Abstract][Full Text] [Related]
4. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy. Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055 [No Abstract] [Full Text] [Related]
5. Redox-sensitive mPEG-SS-PTX/TPGS mixed micelles: An efficient drug delivery system for overcoming multidrug resistance. Zhao D; Zhang H; Yang S; He W; Luan Y Int J Pharm; 2016 Dec; 515(1-2):281-292. PubMed ID: 27746331 [TBL] [Abstract][Full Text] [Related]
6. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells. Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697 [TBL] [Abstract][Full Text] [Related]
7. Aminoglucose-functionalized, redox-responsive polymer nanomicelles for overcoming chemoresistance in lung cancer cells. Zhou Y; Wen H; Gu L; Fu J; Guo J; Du L; Zhou X; Yu X; Huang Y; Wang H J Nanobiotechnology; 2017 Nov; 15(1):87. PubMed ID: 29179722 [TBL] [Abstract][Full Text] [Related]
8. A computer-aided, heterodimer-based "triadic" carrier-free drug delivery platform to mitigate multidrug resistance in lung cancer and enhance efficiency. Yang L; Zhang Y; Lai Y; Xu W; Lei S; Chen G; Wang Z J Colloid Interface Sci; 2025 Jan; 677(Pt B):523-540. PubMed ID: 39154445 [TBL] [Abstract][Full Text] [Related]
9. Stimuli-responsive nanodrug self-assembled from amphiphilic drug-inhibitor conjugate for overcoming multidrug resistance in cancer treatment. Huang P; Wang G; Su Y; Zhou Y; Huang W; Zhang R; Yan D Theranostics; 2019; 9(20):5755-5768. PubMed ID: 31534517 [TBL] [Abstract][Full Text] [Related]
10. pH and redox dual-responsive copolymer micelles with surface charge reversal for co-delivery of all- Zhang Y; Peng L; Chu J; Zhang M; Sun L; Zhong B; Wu Q Int J Nanomedicine; 2018; 13():6499-6515. PubMed ID: 30410335 [TBL] [Abstract][Full Text] [Related]
11. Drug-delivering-drug approach-based codelivery of paclitaxel and disulfiram for treating multidrug-resistant cancer. Mohammad IS; Teng C; Chaurasiya B; Yin L; Wu C; He W Int J Pharm; 2019 Feb; 557():304-313. PubMed ID: 30599232 [TBL] [Abstract][Full Text] [Related]
12. Investigation on vitamin e succinate based intelligent hyaluronic acid micelles for overcoming drug resistance and enhancing anticancer efficacy. Hou L; Tian C; Chen D; Yuan Y; Yan Y; Huang Q; Zhang H; Zhang Z Eur J Pharm Sci; 2019 Dec; 140():105071. PubMed ID: 31525433 [TBL] [Abstract][Full Text] [Related]
13. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance. Zhang J; Zhao X; Chen Q; Yin X; Xin X; Li K; Qiao M; Hu H; Chen D; Zhao X Acta Biomater; 2017 Mar; 50():381-395. PubMed ID: 27956367 [TBL] [Abstract][Full Text] [Related]
14. GSH-responsive poly-resveratrol based nanoparticles for effective drug delivery and reversing multidrug resistance. Liping Y; Jian H; Zhenchao T; Yan Z; Jing Y; Yangyang Z; Jing G; Liting Q Drug Deliv; 2022 Dec; 29(1):229-237. PubMed ID: 35001781 [TBL] [Abstract][Full Text] [Related]
15. Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors. Wang C; Guan W; Peng J; Chen Y; Xu G; Dou H Acta Biomater; 2020 Feb; 103():247-258. PubMed ID: 31846802 [TBL] [Abstract][Full Text] [Related]
16. Novel multi-stimuli responsive functionalized PEG-based co-delivery nanovehicles toward sustainable treatments of multidrug resistant tumor. Xu J; Yan X; Ge X; Zhang M; Dang X; Yang Y; Xu F; Luo Y; Li G J Mater Chem B; 2021 Feb; 9(5):1297-1314. PubMed ID: 33443252 [TBL] [Abstract][Full Text] [Related]
17. Synergistic Combination of Sodium Aescinate-Stabilized, Polymer-Free, Twin-Like Nanoparticles to Reverse Paclitaxel Resistance. Li J; Zheng L; Wang R; Sun D; Liang S; Wu J; Liu Y; Tian X; Li T; Yang Y; Han L Int J Nanomedicine; 2020; 15():5839-5853. PubMed ID: 32848393 [TBL] [Abstract][Full Text] [Related]
18. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo. Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098 [TBL] [Abstract][Full Text] [Related]
19. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer. Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597 [TBL] [Abstract][Full Text] [Related]
20. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells. Bao Y; Guo Y; Zhuang X; Li D; Cheng B; Tan S; Zhang Z Mol Pharm; 2014 Sep; 11(9):3196-209. PubMed ID: 25102234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]